I-Corps: Ultrasensitive Fluorescence Biosensing Platforms for Diagnostics and Molecular Imaging

I-Corps：用于诊断和分子成像的超灵敏荧光生物传感平台

• 批准号: 1562831
• 负责人: Sheila Grant
• 金额: $ 5万
• 依托单位: University of Missouri-Columbia
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-10-15 至 2016-09-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1562831&HistoricalAwards=false
• 关键词: Corps; Ultrasensitive; Fluorescence; Biosensing; Platforms

Clinicians and researchers routinely use single molecule experiments and plate reader based assays to determine the concentration or behavior of a molecule or substance of interest. Currently, researchers utilize signal enhancing substrates and expensive imaging systems such as total internal reflection microscopes (TIR) to obtain better image quality and lower detection limits. Clinicians perform patient diagnostics using diagnostic and test kits which utilize emerging technologies to provide kits with lower detection limits and faster assay times. Typically, these assays require well-trained technicians, expensive equipment and good infrastructure in which to operate. This I-Corps team is developing a platform that can be adapted to the currently used equipment and provide much better performance by enhancing fluorescence signals. This high performance platform is expected to reduce the burden of infrastructure and expensive equipment significantly by eventually being integrated into smartphones to create a point-of-care system.Plasmonic gratings greatly enhance fluorescent signal due to interaction of plasmons and fluorophores. The inexpensive fabrication method of the gratings take advantage of commercially available master molds in the form of CDs, DVDs, and HD-DVDs. Due to the fluorescence enhancement, low detection limit and high signal-to-noise have been achieved. This team envisions three products, slides printed with gratings, microwell plates, and platforms integrated with a smartphone. The I-Corps grant will provide valuable information and training about what is needed to bring this plasmonic grating technology to industrial and clinical markets. During the project, the team will have better understanding of market needs leading to better product designs. The knowledge and experience gained through I-Corps program will be shared with other potential entrepreneurs and students through meetings and presentations. These activities would spread the knowledge and experience to other potential entrepreneur leaders at the University of Missouri as well as surrounding communities.

临床医生和研究人员通常使用单分子实验和基于酶标仪的测定来确定感兴趣的分子或物质的浓度或行为。目前，研究人员利用信号增强基板和昂贵的成像系统，如全内反射显微镜（TIR），以获得更好的图像质量和更低的检测限。临床医生使用诊断和检测试剂盒进行患者诊断，这些试剂盒利用新兴技术提供具有较低检测限和更快测定时间的试剂盒。通常，这些测定需要训练有素的技术人员、昂贵的设备和良好的基础设施来进行操作。这个I-Corps团队正在开发一个平台，可以适应目前使用的设备，并通过增强荧光信号提供更好的性能。这种高性能平台有望通过最终集成到智能手机中创建即时护理系统，从而显著减轻基础设施和昂贵设备的负担。等离子体光栅由于等离子体和荧光团的相互作用而大大增强荧光信号。光栅的廉价制造方法利用了CD、DVD和HD-DVD形式的市售母模。由于荧光增强，实现了低检测限和高信噪比。该团队设想了三种产品，用光栅打印的载玻片，微孔板和与智能手机集成的平台。I-Corps赠款将提供有关将这种等离子光栅技术推向工业和临床市场所需的宝贵信息和培训。在项目期间，团队将更好地了解市场需求，从而更好地设计产品。通过I-Corps计划获得的知识和经验将通过会议和演讲与其他潜在的企业家和学生分享。这些活动将把知识和经验传播给密苏里州大学以及周围社区的其他潜在企业家领袖。